Performance evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Comparison with cobas® EBV for epstein-barr virus DNA quantification in immunocompromised patients, a multicenter study. - Doseeva V; Mostafa HH; Rhoads D; Relich RF; Garner O; Findeisen P; Eigner U; English A; Johnson S (Diagnostic microbiology and infectious disease, 2025)